Omega Healthcare Investors (OHI) EBITDA (2009 - 2026)

Omega Healthcare Investors has disclosed EBITDA across 16 years of filings, most recently posting $330.9 million for Q2 2026.

• In Q2 2026, EBITDA rose 17.66% year-over-year to $330.9 million; the TTM figure through Jun 2026 stood at $1.0 billion (up 28.56% YoY), while the FY2025 annual figure was $839.5 million, up 30.66% from the prior year.
• EBITDA came in at $330.9 million for Q2 2026 at Omega Healthcare Investors, up from $209.7 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $330.9 million in Q2 2026 to a low of $93.3 million in Q1 2023.
• Average EBITDA over 5 years is $181.3 million, with a median of $166.5 million recorded in 2024.
• Year-over-year, EBITDA slumped 63.12% in 2023 and jumped 62.67% in 2025.
• Over 5 years, EBITDA stood at $106.5 million in 2022, then grew by 13.87% to $121.3 million in 2023, then jumped by 43.41% to $173.9 million in 2024, then increased by 28.27% to $223.0 million in 2025, then soared by 48.37% to $330.9 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $330.9 million in Q2 2026, $209.7 million in Q1 2026, and $223.0 million in Q4 2025.